Panagene Inc
Panagene Inc., a leading biotechnology firm headquartered in South Korea (KR), has established itself as a key player in the molecular diagnostics industry since its founding in 2000. With a focus on innovative solutions for cancer diagnostics and personalised medicine, Panagene has developed a range of proprietary technologies that enhance the accuracy and efficiency of genetic testing. The company’s core offerings include advanced PCR-based assays and next-generation sequencing (NGS) products, which are distinguished by their high sensitivity and specificity. Panagene's commitment to research and development has positioned it at the forefront of the industry, earning recognition for its contributions to precision oncology. With a strong presence in both domestic and international markets, Panagene continues to drive advancements in molecular diagnostics, making significant strides in improving patient outcomes.
DitchCarbon Score
How does Panagene Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Panagene Inc's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Panagene Inc's reported carbon emissions
Panagene Inc, headquartered in South Korea (KR), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Panagene Inc may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As a result, the company appears to be in the early stages of addressing its climate impact, with no inherited emissions data from a parent or related organization. Without specific emissions figures or reduction initiatives, it is unclear how Panagene Inc plans to align with global climate goals or contribute to sustainability efforts within its industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Panagene Inc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
